Proof-of-concept Study of Ibrutinib in c-MYC and HER2 Amplified Oesophagogastric Carcinoma
Clinical trial NCT02884453 · UNKNOWN
Trial details
- NCT number
- NCT02884453
- Sponsor
- Royal Marsden NHS Foundation Trust
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-19
- Primary completion
- 2021-12-30
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.